GB8712691D0 - Therapeutic nucleosides - Google Patents

Therapeutic nucleosides

Info

Publication number
GB8712691D0
GB8712691D0 GB878712691A GB8712691A GB8712691D0 GB 8712691 D0 GB8712691 D0 GB 8712691D0 GB 878712691 A GB878712691 A GB 878712691A GB 8712691 A GB8712691 A GB 8712691A GB 8712691 D0 GB8712691 D0 GB 8712691D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic nucleosides
nucleosides
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB878712691A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB878712691A priority Critical patent/GB8712691D0/en
Publication of GB8712691D0 publication Critical patent/GB8712691D0/en
Priority to IL86007A priority patent/IL86007A0/xx
Priority to SU884355537A priority patent/RU1779256C/ru
Priority to AU14444/88A priority patent/AU608590B2/en
Priority to PL1988271722A priority patent/PL154956B1/pl
Priority to DK191688A priority patent/DK191688A/da
Priority to HU881784A priority patent/HU201954B/hu
Priority to CA000563634A priority patent/CA1326237C/en
Priority to KR1019880003964A priority patent/KR880012630A/ko
Priority to FI881651A priority patent/FI87214C/fi
Priority to PT87191A priority patent/PT87191B/pt
Priority to NO881537A priority patent/NO171641C/no
Priority to CS242188A priority patent/CS274461B2/cs
Priority to MC881970A priority patent/MC1915A1/xx
Priority to EP88303158A priority patent/EP0286425B1/en
Priority to APAP/P/1988/000086A priority patent/AP78A/en
Priority to DE3852710T priority patent/DE3852710T2/de
Priority to NZ224189A priority patent/NZ224189A/xx
Priority to JP63087034A priority patent/JP2763888B2/ja
Priority to AT88303158T priority patent/ATE116984T1/de
Priority to NZ224812A priority patent/NZ224812A/xx
Priority to KR1019890700162A priority patent/KR890701582A/ko
Priority to EP88304812A priority patent/EP0294113A1/en
Priority to PCT/GB1988/000424 priority patent/WO1988009332A1/en
Priority to JP88504494A priority patent/JPH02503557A/ja
Priority to IL86533A priority patent/IL86533A0/xx
Priority to ZA883830A priority patent/ZA883830B/xx
Priority to PT87593A priority patent/PT87593B/pt
Priority to AU17962/88A priority patent/AU1796288A/en
Priority to DK725088A priority patent/DK725088A/da
Priority to US07/417,989 priority patent/US5068320A/en
Priority to US07/753,060 priority patent/US5185437A/en
Priority to AU22000/92A priority patent/AU2200092A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB878712691A 1987-04-09 1987-05-29 Therapeutic nucleosides Pending GB8712691D0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
GB878712691A GB8712691D0 (en) 1987-05-29 1987-05-29 Therapeutic nucleosides
IL86007A IL86007A0 (en) 1987-04-09 1988-04-07 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
AT88303158T ATE116984T1 (de) 1987-04-09 1988-04-08 Therapeutische nukleoside.
DE3852710T DE3852710T2 (de) 1987-04-09 1988-04-08 Therapeutische Nukleoside.
NZ224189A NZ224189A (en) 1987-04-09 1988-04-08 6-substituted 2',3'-dideoxynucleosides and pharmaceutical compositions
PL1988271722A PL154956B1 (en) 1987-04-09 1988-04-08 Method of obtaining novel 2',3'-didesoxynucleosides
DK191688A DK191688A (da) 1987-04-09 1988-04-08 Terapeutiske nucleosider
HU881784A HU201954B (en) 1987-04-09 1988-04-08 Process for producing curative nucleosides
CA000563634A CA1326237C (en) 1987-04-09 1988-04-08 Therapeutic nucleosides
KR1019880003964A KR880012630A (ko) 1987-04-09 1988-04-08 치료적 뉴클레오시드
FI881651A FI87214C (fi) 1987-04-09 1988-04-08 Terapeutiska nukleosider
PT87191A PT87191B (pt) 1987-04-09 1988-04-08 Processo para a preparacao de nucleosidos
NO881537A NO171641C (no) 1987-04-09 1988-04-08 Analogifremgangsmaate for fremstilling av 6-substituert-2',3'-dideoksynukleosider
CS242188A CS274461B2 (en) 1987-04-09 1988-04-08 Method of 6-substituted 2,3-dideoxynucleosides production
MC881970A MC1915A1 (fr) 1987-04-09 1988-04-08 Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
EP88303158A EP0286425B1 (en) 1987-04-09 1988-04-08 Therapeutic nucleosides
APAP/P/1988/000086A AP78A (en) 1987-04-09 1988-04-08 Therapeutic nucleosides
SU884355537A RU1779256C (ru) 1987-04-09 1988-04-08 Способ получени нуклеозидов или их фармацевтически приемлемых сложных эфиров
AU14444/88A AU608590B2 (en) 1987-04-09 1988-04-08 Therapeutic nucleosides
JP63087034A JP2763888B2 (ja) 1987-04-09 1988-04-08 治療用ヌクレオシド
AU17962/88A AU1796288A (en) 1987-05-29 1988-05-27 Therapeutic nucleosides
KR1019890700162A KR890701582A (ko) 1987-05-29 1988-05-27 치료용 뉴클레오사이드
ZA883830A ZA883830B (en) 1987-05-29 1988-05-27 Therapeutic nucleosides
EP88304812A EP0294113A1 (en) 1987-05-29 1988-05-27 Therapeutic nucleosides
PCT/GB1988/000424 WO1988009332A1 (en) 1987-05-29 1988-05-27 Therapeutic nucleosides
JP88504494A JPH02503557A (ja) 1987-05-29 1988-05-27 治療用ヌクレオシド
IL86533A IL86533A0 (en) 1987-05-29 1988-05-27 2',3'-dideoxycytidine derivatives,their preparation and pharmaceutical compositions containing them
NZ224812A NZ224812A (en) 1987-05-29 1988-05-27 Derivatives of 2',3'-dideoxycytidine and pharmaceutical compositions
PT87593A PT87593B (pt) 1987-05-29 1988-05-27 Processo para a preparacao de nucleosidos e de composicoes farmaceuticas que os contem
DK725088A DK725088A (da) 1987-05-29 1988-12-28 Terapeutiske nucleosider
US07/417,989 US5068320A (en) 1987-04-09 1989-10-06 2-amino-6-(cyclopropylamino)purine-9-β-D-2',3'-dideoxyribofuranoside and its pharmaceutically acceptable salts
US07/753,060 US5185437A (en) 1987-04-09 1991-08-31 Therapeutic nucleosides
AU22000/92A AU2200092A (en) 1987-05-29 1992-08-28 Therapeutic nucleosides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712691A GB8712691D0 (en) 1987-05-29 1987-05-29 Therapeutic nucleosides

Publications (1)

Publication Number Publication Date
GB8712691D0 true GB8712691D0 (en) 1987-07-01

Family

ID=10618138

Family Applications (1)

Application Number Title Priority Date Filing Date
GB878712691A Pending GB8712691D0 (en) 1987-04-09 1987-05-29 Therapeutic nucleosides

Country Status (9)

Country Link
JP (1) JPH02503557A (pt)
KR (1) KR890701582A (pt)
AU (2) AU1796288A (pt)
GB (1) GB8712691D0 (pt)
IL (1) IL86533A0 (pt)
NZ (1) NZ224812A (pt)
PT (1) PT87593B (pt)
WO (1) WO1988009332A1 (pt)
ZA (1) ZA883830B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108183T1 (de) * 1987-03-24 1994-07-15 Nycomed Imaging As 2',3'-dideoxyribofuranoxid-derivate.
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
CN102070691B (zh) * 2010-12-22 2012-09-19 南京长澳医药科技有限公司 一种美他卡韦晶型,其制备方法以及包含它的药物组合物
US11213960B2 (en) 2018-09-17 2022-01-04 John AMBIELLI Multi-tool and storage device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0206497B1 (en) * 1985-05-15 1994-07-20 The Wellcome Foundation Limited Therapeutic nucleosides and their preparation
AU570855B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of in vitro infectivity and cytopathic effect of htlv-111/lav by 2' 3' -dideoxycytidine

Also Published As

Publication number Publication date
WO1988009332A1 (en) 1988-12-01
KR890701582A (ko) 1989-12-21
PT87593B (pt) 1992-09-30
AU1796288A (en) 1988-12-21
ZA883830B (en) 1990-01-31
IL86533A0 (en) 1988-11-15
NZ224812A (en) 1991-06-25
JPH02503557A (ja) 1990-10-25
AU2200092A (en) 1992-11-12
PT87593A (pt) 1989-05-31

Similar Documents

Publication Publication Date Title
HU210815A9 (en) Therapeutic nucleosides
EP0308065A3 (en) Therapeutic nucleosides
AP8900129A0 (en) Therapeutic nucleosides
EP0434450A3 (en) Therapeutic nucleosides
AP8800086A0 (en) Therapeutic nucleosides
EP0356166A3 (en) Therapeutic nucleosides
EP0287215A3 (en) Therapeutic nucleosides
GB8706176D0 (en) Therapeutic nucleosides
ZA883830B (en) Therapeutic nucleosides
GB8823353D0 (en) Therapeutic nucleosides
GB8912972D0 (en) Therapeutic nucleosides
GB8723793D0 (en) Therapeutic nucleosides
PH29941A (en) Therapeutic nucleosides
GB8723013D0 (en) Therapeutic nucleosides
GB8723746D0 (en) Therapeutic nucleosides
ZA882477B (en) Therapeutic nucleosides
GB8723747D0 (en) Therapeutic nucleosides
IE861273L (en) Therapeutic nucleosides
IE862454L (en) therapeutic nucleosides
IE883328L (en) Therapeutic nucleosides
GB8819732D0 (en) Therapeutic nucleosides
IE881047L (en) Therapeutic nucleosides
IE880748L (en) Therapeutic nucleosides
GB8816284D0 (en) Therapeutic nucleosides
GB8824899D0 (en) Therapeutic nucleosides